scout

Loretta J. Nastoupil, MD, University of Texas MD Anderson Cancer Center

Articles by Loretta J. Nastoupil, MD, University of Texas MD Anderson Cancer Center

Role of Rebiopsy in R/R Follicular Lymphoma

ByIan Flinn, MD, PhD, Sarah Cannon Research Institute,Caron A. Jacobson, MD, Dana-Farber Cancer Institute,Andrew M. Evens, DO, MSc, FACP, Rutgers Cancer Institute of New Jersey,Loretta J. Nastoupil, MD, University of Texas MD Anderson Cancer Center,Krish Patel, MD, Swedish Cancer Institute

The rationale for rebiopsying patients who have relapsed/refractory follicular lymphoma and the types of molecular information that can be applied to treatment decisions.